Dashboard
Manage Tickers

MTVA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
MetaVia To Present Vanoglipel Data For MAS...
10/27/2025 12:43:51

MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today anno...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/17/2025 17:08:10

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/17/2025 12:12:13

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/16/2025 21:06:11

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/16/2025 17:07:35

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/16/2025 12:13:30

why-webtoon-entertainment-shares-are-trading-higher-by-48-here-are-20-stocks-moving-premarket
Why Webtoon Entertainment Shares Are Tradi...
09/16/2025 09:41:12

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/15/2025 21:06:07

Core News & Articles
MetaVia Shares Resume Trade Following Circ...
09/15/2025 19:12:12

Core News & Articles
HC Wainwright & Co. Assumes MetaVia at Buy...
09/04/2025 11:28:24

HC Wainwright & Co. analyst Andrew S. Fein assumes MetaVia (NASDAQ:MTVA) with a Buy rating and announces Price Target of...

Core News & Articles
MetaVia Q2 EPS $(0.26) Beats $(0.31) Estimate
08/07/2025 12:34:42

MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16...

Core News & Articles
MetaVia Extends 48 mg MAD Portion Of Phase...
08/06/2025 12:37:40

Core News & Articles
Metavia Announces A Research Collaboration...
08/04/2025 12:34:05

Partnership Leverages Syntekabio's DeepMatcher® Platform to Expand the Therapeutic Potential ofMetaVia's Oral GPR119 Ag...

Core News & Articles
MetaVia Doses First Patient In 48 Mg, MAD ...
07/09/2025 12:38:47

Top-Line Data Expected in the Fourth Quarter of 2025CAMBRIDGE, Mass., July 9, 2025 /PRNewswire/ -- MetaVia Inc. (NASDAQ:MTVA), ...

Core News & Articles
MetaVia Files For Resale From Time To Time...
07/02/2025 20:09:22

-SEC Filing

Core News & Articles
Reported Saturday, MetaVia Presents Precli...
06/23/2025 08:06:39

Core News & Articles
Watching MetaVia; Zacks Small-Cap Research...
05/22/2025 15:09:21

https://scr.zacks.com/files/News/2025/Zacks_SCR_Research_05222025_MTVA_Bautz.pdf

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
05/22/2025 12:10:00

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
05/20/2025 21:06:07

Core News & Articles
Maxim Group Maintains Buy on MetaVia, Lowe...
05/19/2025 15:59:01

Maxim Group analyst Jason McCarthy maintains MetaVia (NASDAQ:MTVA) with a Buy and lowers the price target from $6 to $3.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION